These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 4053531

  • 1. [A two-center study on the effects of silymarin in pregnant women and adult patients with so-called minor hepatic insufficiency].
    Giannola C, Buogo F, Forestiere G, Scaffidi L, Ferrigno V, Scaffidi A.
    Clin Ter; 1985 Jul 31; 114(2):129-35. PubMed ID: 4053531
    [No Abstract] [Full Text] [Related]

  • 2. [Evaluation of the therapeutic effects of silymarin].
    Margaroli P, Rossi M, Arcabasso GD, Cosini I, Malacrida C.
    Clin Ter; 1980 Dec 31; 95(6):663-72. PubMed ID: 7214856
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of silymarin in intrahepatic cholestasis of pregnancy (preliminary communication)].
    Hernández R, Nazar E.
    Rev Chil Obstet Ginecol; 1982 Dec 31; 47(1):22-9. PubMed ID: 6927150
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S, Gonvers JJ, Hofstetter JR.
    Schweiz Rundsch Med Prax; 1975 May 13; 64(19):595-8. PubMed ID: 51497
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW, Haase W.
    Schweiz Rundsch Med Prax; 1975 Sep 09; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract] [Full Text] [Related]

  • 8. [Metabolic impairment of the hepatocyte in pregnancy: prevention and therapy with a membrane-stabilizing drug].
    Maneschi M, Tiberio C, Cittadini E.
    Clin Ter; 1981 Jun 30; 97(6):625-30. PubMed ID: 6268349
    [No Abstract] [Full Text] [Related]

  • 9. [Milk thistle (Silybum marianum) derivatives in the therapy of chronic hepatopathies].
    De Martiis M, Fontana M, Assogna G, D'Ottavi R, D'Ottavi O.
    Clin Ter; 1980 Aug 15; 94(3):283-315. PubMed ID: 7004762
    [No Abstract] [Full Text] [Related]

  • 10. Use of the Romanian product Silimarina in the treatment of chronic liver diseases.
    Tănăsescu C, Petrea S, Băldescu R, Macarie E, Chiriloiu C, Purice S.
    Med Interne; 1988 Aug 15; 26(4):311-22. PubMed ID: 3072661
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Use of silymarin in the treatment of alcoholic hepatic steatosis].
    Canini F, Bartolucci L, Cristallini E, Gradoli C, Rossi A, Ribacchi R, Valori C.
    Clin Ter; 1985 Aug 31; 114(4):307-14. PubMed ID: 4053546
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Ambulatory treatment of hepatic damage: comparison of 2 therapeutic modalities].
    Ravetta A.
    Clin Ter; 1981 Oct 31; 99(2):149-53. PubMed ID: 7318368
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Silymarin, a membranotropic drug: clinical and experimental observations].
    De Martiis M, Fontana M, Sebastiani F, Parenzi A.
    Clin Ter; 1977 May 31; 81(4):333-62. PubMed ID: 880785
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.